GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Menicon Co Ltd (TSE:7780) » Definitions » Debt-to-Asset

Menicon Co (TSE:7780) Debt-to-Asset : 0.41 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Menicon Co Debt-to-Asset?

Menicon Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円3,051 Mil. Menicon Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円67,955 Mil. Menicon Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was 円173,798 Mil. Menicon Co's debt to asset for the quarter that ended in Dec. 2023 was 0.41.


Menicon Co Debt-to-Asset Historical Data

The historical data trend for Menicon Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Menicon Co Debt-to-Asset Chart

Menicon Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.36 0.32 0.35 0.39

Menicon Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.42 0.41 0.41 0.39

Competitive Comparison of Menicon Co's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, Menicon Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Menicon Co's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Menicon Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Menicon Co's Debt-to-Asset falls into.



Menicon Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Menicon Co's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Menicon Co's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Menicon Co  (TSE:7780) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Menicon Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Menicon Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Menicon Co (TSE:7780) Business Description

Traded in Other Exchanges
Address
3-21-19, Aoi, Naka-ku, Aichi, Nagoya, JPN, 460-0006
Menicon Co Ltd is a contact lens manufacturing company. It is involved in manufacturing, sales, export, and import of contact lenses and other medical goods, manufacturing and sales of medical instruments, sales of medical supplies and research and development of intraocular lenses. The firm's products include soft lenses, gas permeable lenses and lens care products.

Menicon Co (TSE:7780) Headlines

No Headlines